Analyzing the forecast for Italy's antisera and vaccines sold production from 2024 to 2028, we observe a consistent annual increase. From 2024's 542.86 million euros, production is expected to grow to 578.91 million euros by 2028. Sequential year-on-year growth rates indicate a steady uptrend, signifying robust market confidence and demand. Assuming no drastic deviations, the Compound Annual Growth Rate (CAGR) averages out positively over the forecasted period, with incremental growth each year.

Future trends to watch for include:

Technological advancements in vaccine production increasing efficiency and output.
Regulatory changes impacting production capacities and market dynamics.
Potential global health initiatives boosting demand for vaccines and antisera.